Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Breast cancer is a leading cause of mortality among women and is increasing rapidly around the world. For early diagnosis of breast cancer, precise classification, and finding the best subset for cancer identification, evolutionary-based feature selection methods play a vital role in effective treatment. Previous studies have shown that existing evolutionary methods are complicated in correctly differentiating BC disease subtypes with high consistency, which seriously affects the performance of classification methods. To prevent diagnostic errors with hostile implications for patient health, in this study, we develop a new evolutionary method called SeQTLBOGA that incorporates the learner quantization before the search capability of the feature space to prevent premature falls into the local optima. In the SeQTLBOGA algorithm, quantum theory and a self-adaptive mechanism are employed to update the Teaching Learning-based Optimization (TLBO) rule to enhance convergence search capabilities. Most importantly, a self-adaptive genetic algorithm (GA) is also incorporated into TLBO to tradeoff between exploration and exploitation to handle slow convergence and exploitation competence, and simultaneously optimizing parameters of support vector machines (SVM) and the best features subset is our primary objective. Comparative results based on optimal computing time and performance are also offered to empirically analyze the traditional algorithms. Therefore, this paper aims to evaluate the most recent quantum-inspired metaheuristic algorithms in WBCD and WDBC databases, emphasizing their advantages and disadvantages.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144299PMC
http://dx.doi.org/10.1038/s41598-025-05014-zDOI Listing

Publication Analysis

Top Keywords

breast cancer
12
feature selection
8
optimized breast
4
cancer
4
cancer diagnosis
4
diagnosis self-adaptive
4
self-adaptive quantum
4
quantum metaheuristic
4
metaheuristic feature
4
selection breast
4

Similar Publications

Introduction: Cutaneous scalp metastases from breast carcinoma (CMBC) represent an uncommon manifestation of metastatic disease, with heterogeneous clinical presentations, including nodular or infiltrative lesions and scarring alopecia (alopecia neoplastica). The absence of standardized diagnostic criteria, particularly for alopecic phenotypes, poses challenges to early recognition of CMBC, which may represent either the first indication of neoplastic progression or a late recurrence.

Materials And Methods: We retrospectively analyzed a multicenter cohort of 15 patients with histologically confirmed CMBC.

View Article and Find Full Text PDF

PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.

Research (Wash D C)

September 2025

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, characterized by a high propensity for metastasis, poor prognosis, and limited treatment options. Research has demonstrated a substantial correlation between the expression of protein arginine N-methyltransferase 1 (PRMT1) and enhanced proliferation, metastasis, and poor outcomes in TNBC. However, the specific role of PRMT1 in lung metastasis and chemoresistance remains unclear.

View Article and Find Full Text PDF

Purpose: This study aimed to conduct functional proteomics across breast cancer subtypes with bioinformatics analyses.

Methods: Candidate proteins were identified using nanoscale liquid chromatography with tandem mass spectrometry (NanoLC-MS/MS) from core needle biopsy samples of early stage (0-III) breast cancers, followed by external validation with public domain gene-expression datasets (TCGA TARGET GTEx and TCGA BRCA).

Results: Seventeen proteins demonstrated significantly differential expression and protein-protein interaction (PPI) found the strong networks including COL2A1, COL11A1, COL6A1, COL6A2, THBS1 and LUM.

View Article and Find Full Text PDF

A strategy for targeting tumor-associated hypoxia utilizes reductase enzyme-mediated cleavage to convert biologically inert prodrugs to their corresponding biologically active parent therapeutic agents selectively in areas of pronounced hypoxia. Small-molecule inhibitors of tubulin polymerization represent unique therapeutic agents for this approach, with the most promising functioning as both antiproliferative agents (cytotoxins) and as vascular disrupting agents (VDAs). VDAs selectively and effectively disrupt tumor-associated microvessels, which are typically fragile and chaotic in nature.

View Article and Find Full Text PDF

Breast cancer continues to present a major clinical hurdle, largely attributable to its aggressive metastatic behavior and the suboptimal efficacy of standard chemotherapeutic regimens. Cisplatin (CDDP) is a representative platinum drug in the treatment of breast cancer, however, its therapeutic application is often constrained by systemic toxicity and the frequent onset of chemoresistance. Here, we introduce a novel charge-adaptive nanoprodrug system, referred to as PP@, engineered to respond to tumor-specific conditions.

View Article and Find Full Text PDF